iRhythm Technologies (NSDQ:IRTC) posted fourth-quarter results today that beat the consensus forecast on Wall Street while naming the high-level hire the CEO wanted to make when he last spoke with Medical Design & Outsourcing.
The San Francisco-based developer of remote external electrocardiogram monitors reported a net loss of $32.5 million, or $1.10 per share, on sales of $81.8 million for the three months ended Dec. 31, 2021. That quarterly loss grew 235% compared with Q4 2020, while sales grew 3.8%.